Chardan Healthcare Acquisition is Special Purpose Acquisition Company (SPAC) in United States that focus on sclerosing cholangitis business. Founded in 2017. They cover business area such as BiomX Inc, Israel, both natural and engineer phage cocktail, harmful bacteria, skin, chronic disease, inflammatory bowel disease, colorectalcancer, primary sclerose cholangitis.
Special Purpose Acquisition Company (SPAC)
2017
( 7 years old in 2024 )
Sclerosing Cholangitis
-
17 State Street
Suite 2100
New York, NY 10004
United States
Private
BiomX IncIsraelboth natural and engineer phage cocktailharmful bacteriaskinchronic diseaseinflammatory bowel diseasecolorectalcancerprimary sclerose cholangitis
* We use standard office opening hours in near Chardan Healthcare Acquisition's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Chardan Healthcare Acquisition is Special Purpose Acquisition Company (SPAC) business from United States that founded in 2017 (7 years old in 2024), Chardan Healthcare Acquisition business is focusing on Sclerosing Cholangitis.
Chardan Healthcare Acquisition headquarter office and corporate office address is located in 17 State Street Suite 2100 New York, NY 10004 United States.
Chardan Healthcare Acquisition was founded in United States.
In 2024, Chardan Healthcare Acquisition is currently focus on sclerosing cholangitis sector.
Above is snippet of Google Trends for "sclerosing cholangitis" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Chardan Healthcare Acquisition, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
